A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring T-Lymphocytes, Lymphocyte Transformation, HIV-1, Drug Therapy, Combination, Immunosuppressive Agents, Apoptosis, Cyclosporine, Anti-HIV Agents
Eligibility Criteria
Inclusion Criteria You may be eligible for this study if you: Are HIV-positive. Have a CD4 count greater than or equal to 500/mm3. Have a plasma HIV RNA level greater than 600 copies/ml. Are over 18 years of age. Agree to practice abstinence or use barrier methods of birth control during the study. Exclusion Criteria You will not be eligible for this study if you: Have a history of an AIDS-defining illness, autoimmune disease, or hypertension. Have renal disease. Have any active infection other than HIV. Have used certain antiretroviral medications. Are pregnant.
Sites / Locations
- San Francisco Gen Hosp
- Univ of Colorado Health Sciences Ctr
- Northwestern Univ Med School
- Rush Presbyterian - Saint Luke's Med Ctr
- Johns Hopkins Hosp
- Harvard (Massachusetts Gen Hosp)
- Beth Israel Med Ctr
- Bellevue Hosp / New York Univ Med Ctr
- Univ of North Carolina
- Case Western Reserve Univ
- Univ of Texas Med Branch
- Univ of Washington